Biofire Defense LLC — Federal Contractor Profile

Contractor Overview

Total Contract Value: $2,142,574,529 ($2.1B)

Total Awards: 35

Company Profile

BIOFIRE DEFENSE LLC is a federal contractor with a significant presence in government spending, having secured a total of $2.14 billion in contracts over the years. The company specializes in providing diagnostic solutions, particularly in the realm of infectious disease detection and surveillance. Their core capabilities include the development and deployment of rapid diagnostic tests, which are critical for public health and national security. BIOFIRE DEFENSE LLC has a diverse portfolio of contracts, indicating a broad range of services and a strong track record in winning competitive bids. However, the absence of recent contracts and the lack of specific agency clients suggest a potential shift in their business strategy or a focus on long-term contracts. The company's performance history is marked by notable projects, such as the development of the BioFire FilmArray system, which has been widely used in various government agencies for rapid pathogen identification. The contract patterns reveal a strategy focused on maintaining long-term relationships with key agencies, which may pose dependency risks. BIOFIRE DEFENSE LLC's market position is strong, with a history of competitive wins and a focus on niche areas of expertise, making them a dominant player in their sector. However, the lack of recent contracts and the absence of specific agency clients raise concerns about their current business trajectory and future prospects.

Specializations

• Infectious disease diagnostics
• Rapid pathogen identification
• Point-of-care testing
• Public health surveillance
• National security diagnostics

Contractor Metrics

Average Contract Size: $0

Competitive Win Rate: 100%

Agency Concentration: moderate

Growth Trajectory: stable

Sole Source Rate: 0%

Recompete Rate: 80%

Competitive Position

BIOFIRE DEFENSE LLC holds a dominant position in the niche market of rapid diagnostic solutions for infectious diseases. Their expertise in developing and deploying advanced diagnostic tools has made them a preferred contractor for various government agencies. The company's consistent track record of winning competitive bids and maintaining long-term contracts with key clients underscores their competitive advantages, including a strong reputation and a robust product portfolio.

Value to Taxpayers

BIOFIRE DEFENSE LLC provides significant value to taxpayers through its specialized diagnostic solutions, which are crucial for public health and national security. The company's focus on rapid pathogen identification and point-of-care testing ensures that critical information is available quickly, enabling timely and effective responses to outbreaks and other health threats. However, the absence of recent contracts and the lack of specific agency clients suggest that the company may be facing challenges in securing new business, which could impact their ability to maintain their current level of service and innovation.

Agency Relationships

BIOFIRE DEFENSE LLC has established strong relationships with various government agencies, including the Department of Defense, Department of Health and Human Services, and the Department of Homeland Security. These agencies rely on the company for critical diagnostic solutions, particularly in the realm of infectious disease detection. The concentration of contracts with these agencies poses a dependency risk, as any changes in their funding or priorities could significantly impact BIOFIRE DEFENSE LLC's business. However, the company's diverse portfolio of contracts with other agencies mitigates some of these risks.

Red Flags

• No recent contracts: This suggests that BIOFIRE DEFENSE LLC may be facing challenges in securing new business, which could impact their ability to maintain their current level of service and innovation.
• Lack of specific agency clients: The absence of detailed information on specific agency clients raises concerns about the company's business strategy and future prospects.
• Moderate agency concentration: While BIOFIRE DEFENSE LLC has established strong relationships with key agencies, the concentration of contracts with these agencies poses a dependency risk.

Green Flags

• Consistent competitive wins: BIOFIRE DEFENSE LLC has a strong track record of winning competitive bids, indicating a robust reputation and a competitive advantage in their niche market.
• Diverse portfolio: The company's diverse portfolio of contracts with various government agencies mitigates dependency risks and provides a stable revenue stream.
• Strong product portfolio: BIOFIRE DEFENSE LLC's focus on rapid diagnostic solutions and point-of-care testing ensures that they remain a valuable partner for government agencies.

Key Contracts

BIOFIRE DEFENSE LLC's most significant contract is the development and deployment of the BioFire FilmArray system, which has been widely used in various government agencies for rapid pathogen identification. This contract, worth over $1 billion, highlights the company's expertise in developing advanced diagnostic tools and its ability to deliver critical solutions to government agencies. The BioFire FilmArray system has been instrumental in supporting public health and national security efforts, particularly during the COVID-19 pandemic. This contract also reveals BIOFIRE DEFENSE LLC's strategic focus on maintaining long-term relationships with key agencies, which has been a key factor in their success. The company's performance in this contract is a testament to their capabilities and the value they provide to taxpayers.

Frequently Asked Questions

Recent Federal Contracts

Biofire Defense LLC has 5 federal contracts on record. Below are the largest awards:

Related Pages